Stocks to Watch: Samsung, Pepsi, TSMC -- WSJ
Dow Jones2026/10/08 13:55By WSJ Staff Samsung Electronics (KR:005930): The Korean chip company said it expects its operating profit for this quarter to be more than double what it made for all of 2025. Still, shares fell, showing how lofty expectations from AI beneficiaries have become. Chip stocks including Micron (MU), Nvidia (NVDA) and Intel (INTC) also slipped in the U.S. Taiwan Semiconductor Manufacturing (TSM, TW:2330): The chip giant's September sales rose 55% on year, but they were down 0.6% from the previous month. Its U.S.-listed ADRs slipped. PepsiCo (PEP): The snacks and soda maker cut its earnings outlook for the year but said it saw improvement in its underperforming North American business; shares rose. Pacira BioSciences (PCRX): Shares in the pain-drug maker surged after Viatris (VTRS) agreed to buy it for $1.65 billion. This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage). (END) Dow Jones Newswires October 08, 2026 09:55 ET (13:55 GMT)
By WSJ Staff
Samsung Electronics (KR:005930): The Korean chip company said it expects its operating profit for this quarter to be more than double what it made for all of 2025. Still, shares fell, showing how lofty expectations from AI beneficiaries have become.
Chip stocks including Micron (MU), Nvidia (NVDA) and Intel (INTC) also slipped in the U.S.
Taiwan Semiconductor Manufacturing (TSM, TW:2330): The chip giant's September sales rose 55% on year, but they were down 0.6% from the previous month. Its U.S.-listed ADRs slipped.
PepsiCo (PEP): The snacks and soda maker cut its earnings outlook for the year but said it saw improvement in its underperforming North American business; shares rose.
Pacira BioSciences (PCRX): Shares in the pain-drug maker surged after Viatris (VTRS) agreed to buy it for $1.65 billion.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
October 08, 2026 09:55 ET (13:55 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ido Ben-Natan: Frequent on-chain security incidents, AI agents will increase risks
BTC rebounds and breaks through 83,000 USDT, with a 24-hour decrease of 1%
Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly
The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.
Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results
Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.
Crypto prices
More
